MTOR and skin squamous cell carcinoma: Azathioprine is the immunosuppressive drug most closely associated with the risk of developing cSCC, while calcineurin inhibitors (such as tacrolimus and cyclosporine), mycophenolate, belatacept, and mTOR inhibitors have not shown a clear increase in cSCC risk [39].